Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorization from UKMHRA for the three products. These products are Fluoxetine 10mg Capsules, Fluoxetine 30mg Capsules and Fluoxetine 60mg Capsules.
Earlier, the USFDA had issued an Establishment Inspection Report (EIR) for the manufacturing facility of Marksans Pharma located at Verna Industrial estate, Verna, Goa, India.
Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.
